Moderna | MRNA - Trade Debtors


Moderna reported $17M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 166.33M 17.95M Jun/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amgen USD 10.23B 1.09B Jun/2026
Arrowhead Research USD 15.68M 203.19M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Celltrion KRW 2.01T 39.71B Mar/2026
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 1.23M 1.18M Mar/2026
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Kangmei Pharma CNY 2.92B 228.09M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Moderna USD 17M 54M Jun/2026
Organigram Holdings CAD 53.39M 3.45M Mar/2026
Ovoca Bio EUR 53K 14K Dec/2025
Pharma Mar EUR 58.06M 6.87M Jun/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Qiagen NV USD 396.62M 5.99M Mar/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Sartorius EUR 381.2M 14.6M Jun/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 109.07M 2M Sep/2025
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
United Therapeutics USD 310.3M 1.7M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026
Zealand Pharma A/S 259M 81M Mar/2026
Zz Pientze Pharmaceu CNY 1.06B 60.42M Mar/2026